4-Chloro-DL-phenylalanine

4-Chloro-DL-phenylalanine (CAS No.: 7424-00-2) is a synthetic amino acid derivative widely used in biomedical research as a selective inhibitor of tryptophan hydroxylase, the rate-limiting enzyme in serotonin biosynthesis, thereby serving as a key tool for modulating serotonergic signaling. Functioning as a competitive inhibitor in vitro and an irreversible inhibitor in vivo, it effectively reduces endogenous serotonin levels to very low or undetectable concentrations in experimental systems, enabling mechanistic studies of serotonin-dependent pathways. This compound has been shown to influence multiple downstream processes, including regulation of serotonin transport via SERT and modulation of inflammatory and remodeling pathways, such as matrix metalloproteinases, tissue inhibitors of metalloproteinases, and pro-inflammatory cytokines including IL-1β and TNF-α, highlighting its relevance in vascular and inflammatory disease models. In preclinical settings, 4-Chloro-DL-phenylalanine is frequently employed in cell-based assays and animal models to investigate the role of serotonin in neuropsychiatric disorders, reward and pain processing, and neurodegenerative diseases, as well as in studies of pulmonary vascular remodeling and inflammation. Its inhibitory activity is typically observed in the low to moderate micromolar range in vitro, and experimental dosing regimens in vivo are adjusted according to study design to achieve sustained serotonin depletion, making it a valuable pharmacological tool in drug discovery and translational research targeting the serotonergic system.